3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
25
OTHER
7
NIH
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
8
Neoplasms
7
Carcinoma, Hepatocellular
5
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Fibrosis
3
Urinary Bladder Neoplasms
2
Tobacco Use
2
Non-Muscle Invasive Bladder Neoplasms
2
Motor Activity
2
Lymphoma
2
Liver Neoplasms
2
Keratosis, Actinic
2
Hematologic Neoplasms
2
Adenocarcinoma Of Esophagus
2
Ureteral Neoplasms
1
Turcot syndrome
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Tinnitus
1
Thoracic Neoplasms
1
Substance-Related Disorders
1
Solitary Pulmonary Nodule
1
Smoking
1
Small Cell Lung Carcinoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Patient Compliance
1
Ototoxicity
1
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Hereditary Sensory and Autonomic Neuropathies
×
1 year
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled